FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170422286> ?p ?o ?g. }

• W2170422286 endingPage "e7675" @default.
• W2170422286 startingPage "e7675" @default.
• W2170422286 abstract "Since its advent, structural biology has played a major role in the understanding of biological processes at the molecular level. This, in turn, has enabled the progression and development of several fields in biological sciences. As a consequence there has been a continuing demand for faster and more cost-effective determination of protein structures and their in-depth functional, mechanistic and biological analysis. The lack of a well-established process historically meant that structures were been solved in a case-by-case manner, with academic researchers establishing specific protocols over a relatively long period of time that are difficult to implement or inappropriate for high-throughput approaches. As the sequencing of the human genome was completed the gap between known genes and solved protein structures became wider. As a result concerted and systematic technology-driven ‘structural genomics’ (SG) efforts to solve protein structures in a high throughput manner were begun (for thorough reviews see [1], [2]).First formalised in 1998 [3]–[5], several major SG efforts were subsequently started such as the NIH-funded Protein Structure Initiative (PSI; http://www.nigms.nih.gov/Initiatives/PSI), European initiatives ‘The Protein Structure Factory (PSF; http://www.proteinstrukturfabrik.de) and ‘Structural Proteomics in Europe (SPINE; http://www.spineurope.org) and Japanese Protein 3000 and RIKEN Structural Genomics/Proteomics programs (http://protein.gsc.riken.jp). The majority of these early programmes were tasked with exploring the breadth of the protein structural universe by focussing on prokaryotic targets whilst driving novel structural biology technology for a high-throughput environment [1], [6].New avenues have been opened by the availability of detailed structural descriptions of proteins and enzymes involved in the normal (or abnormal) functioning of the human body and associated pathogens. In particular, this information provides a better understanding of the basis by which different proteins achieve selectivity and specific binding to their cognate ligands and drugs [1]. Indeed, several marketed drugs in recent years have been developed using structure-based methods, targeting a wide range of disease such as AIDS, leukaemia, cancers and venous thromboembolic events [1], [7]–[10].Despite these successes, determining the structures of human proteins in a high-throughput manner was seen to be technically challenging relative to those of less complex organisms (e.g. prokaryotes), where issues such as the lack of solubility of expressed proteins in simple bacterial systems pose major bottlenecks to scaling the structure determination process [11]. The SGC (http://www.thesgc.org) was created in 2003 as a response to this challenge.The SGC is a not-for-profit organisation that aims to solve the three dimensional structures of proteins of medical relevance and place them into the public domain without encumbrance or restriction. The SGC has adopted a protein-family based approach whereby protein targets are chosen from discrete and medically-relevant human protein families. This approach ensures that comparative analysis and “blanket” methods can be applied to members of same family [11]. The SGC is driving the concept of “open-source science” to enable drug discovery by promoting pre-competitive structural biology and medicinal chemistry. This is achieved by combining academic and industrial efforts to create open-access chemical and clinical probes [12]–[14] which might be used in a pre-competitive manner for target validation purposes, for example.Since the production phase of the SGC began in 2004, we have released the coordinates of over 800 protein structures related to several diseases and metabolic disorders into the public domain of which over 700 are novel and unique. Whilst the SGC focuses primarily on human targets, we also pursue the structure determination of proteins from parasitic organisms associated with neglected diseases, such as malaria and toxoplasmosis. We have deposited more than 70 of these structures into the public domain. These structures are providing a significant impact with the SGC providing 61% of publicly available apicomplexan structures. The SGC has also developed new protocols and methods that are now widely used [15]–[18] and is developing chemical probes [19] and small molecules in areas such as human epigenetics and human protein kinases, to be placed in the public domain [1] as part of the ‘open-source’ science approach.In this PLoS ONE Collection we present articles covering the structure determination of a number of targets by the SGC along with additional work carried out to further characterise these proteins. Since SG data is intrinsically heterogeneous and not always accessible to non-specialists, all the articles from this collection are available also as an enhanced version using our interactive visualisation platform – known as iSee – which allows the reader to interact and manipulate the 3D scenes prepared by the authors to highlight and support information given in the main text of the article [20]." @default.
• W2170422286 created "2016-06-24" @default.
• W2170422286 creator A5012850513 @default.
• W2170422286 creator A5061314864 @default.
• W2170422286 creator A5064101943 @default.
• W2170422286 creator A5078209681 @default.
• W2170422286 date "2009-10-20" @default.
• W2170422286 modified "2023-09-25" @default.
• W2170422286 title "SGC - Structural Biology and Human Health: A New Approach to Publishing Structural Biology Results" @default.
• W2170422286 cites W1523838071 @default.
• W2170422286 cites W1869516088 @default.
• W2170422286 cites W1965578150 @default.
• W2170422286 cites W1981076832 @default.
• W2170422286 cites W1983509096 @default.
• W2170422286 cites W2000106654 @default.
• W2170422286 cites W2000584915 @default.
• W2170422286 cites W2001314811 @default.
• W2170422286 cites W2011962806 @default.
• W2170422286 cites W2014259223 @default.
• W2170422286 cites W2020481171 @default.
• W2170422286 cites W2023040612 @default.
• W2170422286 cites W2029087609 @default.
• W2170422286 cites W2029667189 @default.
• W2170422286 cites W2039377812 @default.
• W2170422286 cites W2048205675 @default.
• W2170422286 cites W2058730349 @default.
• W2170422286 cites W2064463982 @default.
• W2170422286 cites W2081655977 @default.
• W2170422286 cites W2086358466 @default.
• W2170422286 cites W2101747678 @default.
• W2170422286 cites W2105844209 @default.
• W2170422286 cites W2116435022 @default.
• W2170422286 cites W2121795229 @default.
• W2170422286 cites W2125314454 @default.
• W2170422286 cites W2136299394 @default.
• W2170422286 cites W2136726091 @default.
• W2170422286 cites W2137184377 @default.
• W2170422286 cites W2140763734 @default.
• W2170422286 cites W2143373491 @default.
• W2170422286 cites W240501384 @default.
• W2170422286 cites W4246711574 @default.
• W2170422286 cites W4248518927 @default.
• W2170422286 doi "https://doi.org/10.1371/journal.pone.0007675" @default.
• W2170422286 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2762615" @default.
• W2170422286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19847312" @default.
• W2170422286 hasPublicationYear "2009" @default.
• W2170422286 type Work @default.
• W2170422286 sameAs 2170422286 @default.
• W2170422286 citedByCount "17" @default.
• W2170422286 countsByYear W21704222862012 @default.
• W2170422286 countsByYear W21704222862013 @default.
• W2170422286 countsByYear W21704222862014 @default.
• W2170422286 countsByYear W21704222862015 @default.
• W2170422286 countsByYear W21704222862019 @default.
• W2170422286 countsByYear W21704222862020 @default.
• W2170422286 countsByYear W21704222862021 @default.
• W2170422286 crossrefType "journal-article" @default.
• W2170422286 hasAuthorship W2170422286A5012850513 @default.
• W2170422286 hasAuthorship W2170422286A5061314864 @default.
• W2170422286 hasAuthorship W2170422286A5064101943 @default.
• W2170422286 hasAuthorship W2170422286A5078209681 @default.
• W2170422286 hasBestOaLocation W21704222861 @default.
• W2170422286 hasConcept C152662350 @default.
• W2170422286 hasConcept C171852809 @default.
• W2170422286 hasConcept C191120209 @default.
• W2170422286 hasConcept C54355233 @default.
• W2170422286 hasConcept C70721500 @default.
• W2170422286 hasConcept C84084929 @default.
• W2170422286 hasConcept C86803240 @default.
• W2170422286 hasConcept C95444343 @default.
• W2170422286 hasConceptScore W2170422286C152662350 @default.
• W2170422286 hasConceptScore W2170422286C171852809 @default.
• W2170422286 hasConceptScore W2170422286C191120209 @default.
• W2170422286 hasConceptScore W2170422286C54355233 @default.
• W2170422286 hasConceptScore W2170422286C70721500 @default.
• W2170422286 hasConceptScore W2170422286C84084929 @default.
• W2170422286 hasConceptScore W2170422286C86803240 @default.
• W2170422286 hasConceptScore W2170422286C95444343 @default.
• W2170422286 hasIssue "10" @default.
• W2170422286 hasLocation W21704222861 @default.
• W2170422286 hasLocation W21704222862 @default.
• W2170422286 hasLocation W21704222863 @default.
• W2170422286 hasLocation W21704222864 @default.
• W2170422286 hasLocation W21704222865 @default.
• W2170422286 hasLocation W21704222866 @default.
• W2170422286 hasOpenAccess W2170422286 @default.
• W2170422286 hasPrimaryLocation W21704222861 @default.
• W2170422286 hasRelatedWork W2043147644 @default.
• W2170422286 hasRelatedWork W2089089845 @default.
• W2170422286 hasRelatedWork W2115786648 @default.
• W2170422286 hasRelatedWork W2165298019 @default.
• W2170422286 hasRelatedWork W2170422286 @default.
• W2170422286 hasRelatedWork W2293705795 @default.
• W2170422286 hasRelatedWork W2898595765 @default.
• W2170422286 hasRelatedWork W2899355814 @default.
• W2170422286 hasRelatedWork W2921334121 @default.
• W2170422286 hasRelatedWork W3099865896 @default.
• W2170422286 hasVolume "4" @default.

• next